Karen Frascello

Director, Global Medical Affairs, Early Access at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Karen Frascello's Colleagues at Alnylam Pharmaceuticals
Jessica McCoy

Associate Director, Clinical Operations - Global Trial Optimization

Contact Jessica McCoy

Tim Carey

Associate Director - IT Validation and Compliance

Contact Tim Carey

Leko Lin

Associate Director, Medical Information & Review

Contact Leko Lin

Paul Medeiros

Associate Director, Manufacturing

Contact Paul Medeiros

View All Karen Frascello's Colleagues
Karen Frascello's Contact Details
HQ
(617) 551-8200
Location
Cambridge,Massachusetts,United States
Company
Alnylam Pharmaceuticals
Karen Frascello's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Karen Frascello
Karen Frascello currently works for Alnylam Pharmaceuticals.
Karen Frascello's role at Alnylam Pharmaceuticals is Director, Global Medical Affairs, Early Access.
Karen Frascello's email address is ***@alnylam.com. To view Karen Frascello's full email address, please signup to ConnectPlex.
Karen Frascello works in the SaaS industry.
Karen Frascello's colleagues at Alnylam Pharmaceuticals are Elane Fishilevich, Jessica McCoy, Doug Maley, Tim Carey, Leko Lin, Poushali Mukherjea, Paul Medeiros and others.
Karen Frascello's phone number is (617) 551-8200
See more information about Karen Frascello